ArticleFrontiers in pharmacology2025

Pterostilbene mitigates experimental pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition.

Jie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.